Condition
Henoch-Schoenlein Purpura
Total Trials
7
Recruiting
0
Active
0
Completed
6
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 7 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 6 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 2 (1)
Trial Status
Completed6
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (7)
Showing 7 of 7 trials
NCT02540720Phase 2UnknownPrimary
The Research of Standard Diagnosis and Treatment for Severe HSP in Children
NCT02476292Completed
Impact of Vasculitis on Employment and Income
NCT02190916Completed
Vasculitis Illness Perception (VIP) Study
NCT02190929Completed
Educational Needs of Patients With Systemic Vasculitis
NCT02176070Completed
Reproductive Health in Men and Women With Vasculitis
NCT00190229Not ApplicableCompletedPrimary
Efficacy of Steroid Versus Steroid Plus Cyclophosphamide for Severe Henoch-Schoenlein Purpura
NCT00301613Not ApplicableCompletedPrimary
Mycophenolate Mofetil (MMF) Versus Intravenous CTX Pulses in the Treatment of Adult Severe HSPN
Showing all 7 trials